Page last updated: 2024-09-03

tyrosyl-prolyl-tryptophyl-glycinamide and deltorphin ii, ala(2)-

tyrosyl-prolyl-tryptophyl-glycinamide has been researched along with deltorphin ii, ala(2)- in 1 studies

Compound Research Comparison

Studies
(tyrosyl-prolyl-tryptophyl-glycinamide)
Trials
(tyrosyl-prolyl-tryptophyl-glycinamide)
Recent Studies (post-2010)
(tyrosyl-prolyl-tryptophyl-glycinamide)
Studies
(deltorphin ii, ala(2)-)
Trials
(deltorphin ii, ala(2)-)
Recent Studies (post-2010) (deltorphin ii, ala(2)-)
2500233020

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujimura, T; Ito, K; Kawamura, S; Mizoguchi, H; Murayama, K; Nakayama, D; Sakurada, C; Sakurada, S; Sakurada, T; Sato, T; Watanabe, C; Watanabe, H1

Other Studies

1 other study(ies) available for tyrosyl-prolyl-tryptophyl-glycinamide and deltorphin ii, ala(2)-

ArticleYear
A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 312, Issue:3

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Male; Mice; MSH Release-Inhibiting Hormone; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Receptors, Opioid, mu

2005